Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Dansk
English
Søg efter indhold i Region Hovedstadens forskningsportal
Forside
Hospitaler/Afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Public health implications of altered puberty timing
Mari S Golub
, Gwen W Collman
, Paul M D Foster
, Carole A Kimmel
,
Ewa Rajpert-De Meyts
, Edward O Reiter
, Richard M Sharpe
,
Niels E Skakkebaek
,
Jorma Toppari
Afdeling for Vækst og Reproduktion
449
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Public health implications of altered puberty timing'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Medicine and Dentistry
Public Health
100%
Cognition
100%
Prematurity
50%
Maturity Onset Diabetes of the Young
50%
Cardiovascular Disease
50%
Cohort Effect
50%
Metabolic Syndrome
50%
Testis Cancer
50%
Breast Cancer
50%
Maturation
50%
Child Health
50%
Endocrine Disruptor
50%
Menarche
50%
Adrenarche
50%
Reproductive Toxicity
50%
Bone Maturation
50%
Conduct Disorder
50%
Reproductive System Cancer
50%
Adult Disease
50%
Toxicity Testing
50%
Adolescence
50%
Adverse Effect
50%
Keyphrases
Puberty Timing
100%
Public Health Impact
100%
Risk Assessment
40%
Chemical Testing
40%
Cardiovascular Disease
20%
High Risk
20%
Adverse Effects
20%
Breast Cancer Risk
20%
Adulthood
20%
Adult Height
20%
Metabolic Syndrome
20%
Female Rats
20%
Conduct Disorder
20%
Testicular Cancer
20%
Puberty
20%
Prepubertal Rats
20%
Children's Health
20%
Male Puberty
20%
Early Puberty
20%
Premature Adrenarche
20%
Endocrine Tests
20%
Psychosocial Problems
20%
Menarche Age
20%
Epidemiologic Studies
20%
Obesity Type
20%
Behavioral Disorders
20%
Early Maturation
20%
Reproductive Toxicity
20%
Toxicological Risk Assessment
20%
United States Environmental Protection Agency (USEPA)
20%
Adult Disease
20%
Chemical Risk
20%
Reproductive Tract
20%
Skeletal Maturation
20%
Testing Approaches
20%
Behavior Disorders
20%
Toxicity Testing
20%
Agency Risk
20%
US Legislation
20%
Endocrine Disrupting Agents
20%
Test Guideline
20%
Type II Diabetes Disease
20%
Child Screening
20%
Nursing and Health Professions
Behavior Disorder
100%
Public Health
100%
Practice Guideline
50%
Breast Cancer
50%
Cardiovascular Disease
50%
Adolescent
50%
Testis Cancer
50%
Prematurity
50%
Metabolic Syndrome X
50%
Endocrine Disruptor
50%
Conduct Disorder
50%
Environmental Protection
50%
Reproductive Toxicity
50%
Toxicity Testing
50%
Maturity Onset Diabetes of the Young
50%
Rat
50%
Adult Disease
50%
Adverse Effect
50%